COST MANAGEMENT: HOW CONVENIENT IS HOME HEMODIALYSIS?

Similar documents
What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

2015 Investor Conference

FIRST RENAL REPLACEMENT

Improving global access to integrated ESKD care. David Harris 01/10/17

United States Renal Data System (USRDS) International Data Collection Form

Chapter 6: Medicare Expenditures for CKD

Difference in practical dialysis therapy between East Asia and US/EU

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

Who is a Candidate for Home Dialysis? Why We Chose Home Dialysis. Midwest Kidney Network September 2016

CKD Screening in Developing Countries. The case of Jalisco, Mexico.

Does Hemodialysis or Peritoneal Dialysis Provide a Better Quality of Life for Those with Chronic Kidney Disease? University of New Hampshire

Acceptance onto dialysis guidelines: St George Hospital

Management of the Frail Older Patients: What Are the Outcomes

Chapter 6: Healthcare Expenditures for Persons with CKD

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

abstract Background Advancing the study&understanding of self-care

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

Global End Stage Renal Disease (ESRD) Market With Focus on Dialysis Market ( Edition) July 2017

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

USRDS UNITED STATES RENAL DATA SYSTEM

KIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You

Time to Reduce Mortality in End Stage Renal Disease (TiME)

Status of the CKD and ESRD treatment: Growth, Care, Disparities

It is important upfront to realize and believe that, like many adults,

The Burden of Kidney Disease in Rural & Northern Ontario

ASDIN 7th Annual Scientific Meeting

Measure Information Form

Research Article Chronic Kidney Disease: Evolution of Healthcare Costs and Resource Consumption from Predialysis to Dialysis in Piedmont Region, Italy

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

morbidity & mortality

USRDS UNITED STATES RENAL DATA SYSTEM

ASN s Legislative Priorities for 2010

Edward Jones, MD KCP Chairman Gail Wick, MHSA, BSN, RN, CNN Allen Nissenson, MD

STATEMENT OF THE NATIONAL KIDNEY FOUNDATION SUBMITTED TO THE HOUSE COMMITTEE ON APPROPRIATIONS;

CKD Prevention Program Protocol

Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis

Niagara Health Quality Coalition Employers Leading The Way In Health Care Quality

The Conundrum of First Dialysis Modality in Diabetic Patients with ESKD

Il paziente anziano, evidenza e survey nazionale

Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment options Gonzalez-Perez J G, Vale L, Stearns S C, Wordsworth S

Chapter 10: Dialysis Providers

ADVANCE CARE PLANNING FOR KIDNEY PATIENTS: THE IMPORTANCE OF AN ONGOING DISCUSSION

Focus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

Experts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis

Patient s Experience with Home Hemodialysis: A Qualitative Study

Geriatric Nephrology. Murtener Tage

2013 Community Benefit Report

year in review 2015/2016 manitoba renal program Winnipeg Regional Health Authority manitoba renal program

Chapter Five Clinical indicators & preventive health

Dialysis outcomes: can we do better?

New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries

Utopia Health Career Center, LLC. Do not distribute without permission.

Andrea Pizutti, LCSW Gayle Hall, BSN, RN, CNN Regional Operations Director Area Director Davita NxStage Kidney Care

The National Kidney Foundation (NKF) is pleased to submit testimony regarding the impact of

Diane Watson, RN, MSc, C Neph (C) APN, Nephrology, UHN

Evidence-based practice in nephrology : Meta-analysis

CHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition

Agroup of clinicians, researchers, ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote

Global Perspectives in CKD: Opportunities and Challenges to improve outcomes around the world

The vexing problem of suboptimal initiation of dialysis: Can we do better?

Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1

Christopher R. Blagg. Turkish Society of Nephrology

Palliative and End of Life Care in End Stage Renal Disease

Management of End Stage Renal Disease-Bangladesh Perspective

04 Chapter Four Treatment modalities. Experience does not err, it is only your judgement that errs in expecting from her what is not in her power.

2012 Community Benefit RepoRt

ASDIN 8th Annual Scientific Meeting

2008 Dialysis Facility Report

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management

Chapter 25: Interactions of Dialysis Teams With Geriatricians

Chapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Starting with Home Dialysis. Budapest Nephrology School 2016 Ágnes Haris MD, PhD, Kálmán Polner MD St. Margit Hospital, Budapest

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

Department of Nephrology

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Your Kidney Health. Your Choices. Chronic Kidney Disease

Reviewing Implementation Issues in Dialysis: Challenges and Opportunities. EFTYHIA HELIS, MSc KNOWLEDGE MOBILIZATION

USRDS UNITED STATES RENAL DATA SYSTEM

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain

Disclosures. Outline 6/12/2018. Telehealth Strategies for Extending HIV Prevention and Care Services

The Transitional Care Unit: An out of the box approach to expand Home Dialysis. What was US patients modality selection in 1996, 2006 and 2014?

Renalyx Extending Renal Health

TELENEPHROLOGY: EXPERIENCE CARING FOR HOSPITALIZED PATIENTS IN A RURAL COMMUNITY HOSPITAL (1,978 VISITS OVER 2 YEARS)

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

PATIENTS WITH SIX CANNULATION SITES FOR HEMODIALYSIS CORRELATED WITH DECREASED OCCURRENCE OF AV SHUNT THROMBOSIS IN TAIPEI HOSPITAL

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

All patients suitable for home dialysis should do PD first

Chapter six Outcomes: hospitalization & mortality. There is an element of death in life, and I am astonished

Factors Affecting Quality of Life in Patients with End Stage of Renal Disease on Hemodialysis, Ras Al Khaimah-United Arab Emirates

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Transcription:

Unione Europea Bando "Aiuti a Sostegno dei Cluster Tecnologici Regionali " COST MANAGEMENT: HOW CONVENIENT IS HOME HEMODIALYSIS? Maria Pia dell Oglio, Clinical Pathologist, Ph.D

BACKGROUND Renal replacement therapy, dialysis or kidney transplantation, is a life-supporting still high-cost treatment for patients with End-Stage Renal Disease (ESRD) that is a dominant reason of mortality and morbidity worldwide. Webster AC, et al. Chronic Kidney Disease. Lancet. 2016; 22:1-15. In the next decade, prevalence of the disease and universal use of RRT are hypothesized to increase significantly. In 2010, more than 2 million people received RRT worldwide and the application of RRT is thrown to more than double to 5.5 million people by 2030, principally in developing regions such as Africa and Asia. Liyanage T, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015. 16;385(9981):1975-82.

Total Medicare Expenditures for Persons With ESRD Between 2013 and 2014, ESRD patients account for almost 7.2% of Medicare expenditures with a total cost for health service of $32.8 billion annually. PD remained less costly on a per patient basis in 2014 ($73.612) than HD ($87.638). Transplant spending in 2014 increased from 2013 ($32.586) and remained far lower than spending for either dialysis modality. 2016 USRDS ANNUAL DATA REPORT ESRD IN THE UNITED STATES

Epidemiology of CKD: the CARHES study The CARHES (CArdiovascular Risk in Renal patients of the Italian Health Examination Survey) study, conducted by the SIN in collaboration with the SIC and the SSN (Superior Health Institute), estimated that the Italian prevalence of chronic kidney disease (CKD) is 6.3% in a representative sample of the Italian population aged between 35 and 79 years. Based on these epidemiologic data, there are about 2.5-3 millions of people with CKD and this number is expected to increase over time for aging population. Conte G, et al. Epidemiologia della malattia renale cronica in Italia e strategie per la prevenzione. G Ital Nefrol 2014; 31 (4).

The Italian public healthcare expenditure: CKD PIL = 1883 Billions Annual Healthcare budget (FSN) = 6.8 % of PIL = 113 Billions CKD = 6 billion/year = 5.3 % of FSN

The Italian public healthcare expenditure: dialysis modality In 2016, it was estimated in Italy that the prevalence of ESRD were 0.084% and consume 2.2% of the annual healthcare budget (FSN), equivalent to 2.5 billion/year (25 times the cost of health care/patient), because ageing of the world s population is leading to a considerable increase in the numbers of individuals with ESRD and the treatment is very expensive.

Epidemiological data 45000 Hemodialysis-in center patients 4400 Peritoneal Dialysis patients 200 Home Hemodialysis patients 4400 Hemodialysis-in center patients 300 Peritoneal Dialysis patients 15 Home Hemodialysis patients

The Italian Healthcare expenditure A considerable amount of healthcare funding is spent on treating dialysis patients: 75% of healthcare is paid for by public funds; only 25% by private funds. Any uncontrolled growth of such spending could eventually represent a significant risk to the sustainability of Italian public budget. Pontoriero G, et al. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ. 2007;7(2-3):201-15.

TELEMEDICINE Defined by the World Health Organization (WHO) as The monitoring and management of patients, as well as the education of patients and staff, using systems that provide prompt access to expert advice and patient information, regardless of where the patient or information resides. The telecommunication system in the promotion of public health generates different positive results: highest quality of heath care service, more efficiency, less costs and better patient s QOL. WHO. A health telematics policy in support of WHO s Health for all strategy for global Health development. Report of the WHO group consultation on Health telematics. 1998

Tele dialysis program Platform innovative Hospital Basic physician Dialysis staffing Nurses, dialysis technicians, nephrologist prepared to give unique and essential indications Patient prepared to self-administer, provide information, accept and apply the provided information (Patient Empowerment)

Home Video camera alta risoluzione Control Room (Operative Hospital Central) Bilancia pesa persone Router e Mini Pc Data flow and clinical indication

HEALTHCARE COSTS OF HHD Reduced travel costs for patients Dropped hospitalizations and hospital days Decreased drug costs due to improved blood pressure and better CKD-MBD control Diminished staffing costs (nurses, dialysis technicians, nephrologists) Decreased dialysis center management costs Horward et al. Funding and planning: what you need to know for starting or expanding a home hemodialysis program. Hemodial Int. 2015; 19:S23 S42

Hemodialysis: Modality The hemodialysis therapies can be dispensed by different locations: In-center or hospital HD; Satellite HD or self-care units (independent, but not at patient's home); Home HD (HHD) with telemonitoring in Operative Hospital Central ( Control Room ).

Hemodialysis: Modality HD-in center HHD modality 3 times per week for 4-5 hours 5-6 times a week for 3 hours 156 treatments per year 260-310 treatments per year Young BA, Chan C., Blagg C. et al. How to overcome barriers and establish a successful home HD program. CJASN 2012;7:2023-2032.